Article
Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease.
Journal of translational medicine - 11 Dec 2017
Nuij V J A A, Peppelenbosch M P, van der Woude C J, Fuhler G M
Abstract excerpt
BACKGROUND: The role of single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD) is gaining interest. With the advent of novel therapies, personalized treatment in IBD is a future goal. We wondered whether IBD-associated SNPs are able to predict response to anti-TNFα treatment. METHODS: Data on treatment use and primary response, loss of response and side effects to anti-TNFα...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
